Paradigm changes and the future of HIV vaccine research: A summary of a workshop held in Baltimore on 20 November 2013

Marc H.V. Van Regenmortel; Jean Marie Andrieu; Dimiter S. Dimitrov; Barbara Ensoli; Catarina E. Hioe; Christiane Moog; Ruth M. Ruprecht

doi:10.4172/2155-6113.1000281

Paradigm changes and the future of HIV vaccine research: A summary of a workshop held in Baltimore on 20 November 2013

Marc H.V. Van Regenmortel
, Jean Marie Andrieu
, Dimiter S. Dimitrov
, Barbara Ensoli
, Catarina E. Hioe
, Christiane Moog
, Ruth M. Ruprecht

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

A workshop entitled: "What type of HIV Vaccine research should be promoted" took place during a virology conference held in Baltimore in November 2013 (www.omicsgroup.com/conferences/virology-2013/). The purpose of this workshop was to discuss new paradigms that better fit our increased knowledge of HIV immunopathology and which could possibly be more helpful in guiding future vaccine research than did past unsuccessful approaches. Panelists were asked to respond to four questions regarding possible novel paradigms that could guide future HIV vaccine research and their responses are summarized.

Original language	English
Article number	1000281
Journal	Journal of AIDS and Clinical Research
Volume	5
Issue number	3
DOIs	https://doi.org/10.4172/2155-6113.1000281
State	Published - 2014
Externally published	Yes

Keywords

Antibody maturation
HIV vaccines
Immunogenicity
Paradigms
Research funding
Reverse vaccinology
Tat vaccine

Access to Document

10.4172/2155-6113.1000281

Cite this

@article{b7d60568e7a94d2ab3cef22e6bdacdf8,

title = "Paradigm changes and the future of HIV vaccine research: A summary of a workshop held in Baltimore on 20 November 2013",

abstract = "A workshop entitled: {"}What type of HIV Vaccine research should be promoted{"} took place during a virology conference held in Baltimore in November 2013 (www.omicsgroup.com/conferences/virology-2013/). The purpose of this workshop was to discuss new paradigms that better fit our increased knowledge of HIV immunopathology and which could possibly be more helpful in guiding future vaccine research than did past unsuccessful approaches. Panelists were asked to respond to four questions regarding possible novel paradigms that could guide future HIV vaccine research and their responses are summarized.",

keywords = "Antibody maturation, HIV vaccines, Immunogenicity, Paradigms, Research funding, Reverse vaccinology, Tat vaccine",

author = "\{Van Regenmortel\}, \{Marc H.V.\} and Andrieu, \{Jean Marie\} and Dimitrov, \{Dimiter S.\} and Barbara Ensoli and Hioe, \{Catarina E.\} and Christiane Moog and Ruprecht, \{Ruth M.\}",

year = "2014",

doi = "10.4172/2155-6113.1000281",

language = "English",

volume = "5",

journal = "Journal of AIDS and Clinical Research",

issn = "2155-6113",

publisher = "OMICS Publishing Group",

number = "3",

}

TY - JOUR

T1 - Paradigm changes and the future of HIV vaccine research

T2 - A summary of a workshop held in Baltimore on 20 November 2013

AU - Van Regenmortel, Marc H.V.

AU - Andrieu, Jean Marie

AU - Dimitrov, Dimiter S.

AU - Ensoli, Barbara

AU - Hioe, Catarina E.

AU - Moog, Christiane

AU - Ruprecht, Ruth M.

PY - 2014

Y1 - 2014

N2 - A workshop entitled: "What type of HIV Vaccine research should be promoted" took place during a virology conference held in Baltimore in November 2013 (www.omicsgroup.com/conferences/virology-2013/). The purpose of this workshop was to discuss new paradigms that better fit our increased knowledge of HIV immunopathology and which could possibly be more helpful in guiding future vaccine research than did past unsuccessful approaches. Panelists were asked to respond to four questions regarding possible novel paradigms that could guide future HIV vaccine research and their responses are summarized.

AB - A workshop entitled: "What type of HIV Vaccine research should be promoted" took place during a virology conference held in Baltimore in November 2013 (www.omicsgroup.com/conferences/virology-2013/). The purpose of this workshop was to discuss new paradigms that better fit our increased knowledge of HIV immunopathology and which could possibly be more helpful in guiding future vaccine research than did past unsuccessful approaches. Panelists were asked to respond to four questions regarding possible novel paradigms that could guide future HIV vaccine research and their responses are summarized.

KW - Antibody maturation

KW - HIV vaccines

KW - Immunogenicity

KW - Paradigms

KW - Research funding

KW - Reverse vaccinology

KW - Tat vaccine

UR - https://www.scopus.com/pages/publications/84898876770

U2 - 10.4172/2155-6113.1000281

DO - 10.4172/2155-6113.1000281

M3 - Review article

AN - SCOPUS:84898876770

SN - 2155-6113

VL - 5

JO - Journal of AIDS and Clinical Research

JF - Journal of AIDS and Clinical Research

IS - 3

M1 - 1000281

ER -

Paradigm changes and the future of HIV vaccine research: A summary of a workshop held in Baltimore on 20 November 2013

Abstract

Keywords

Access to Document

Fingerprint

Cite this